journal european neuropsychopharmacology ran supplement issue sepotember titled september pages clinic community treating whole schizophrenic patient innovation psychiatric therapy promise new antipsychotics supplement issue journal issue paid drug companies glaxosmithkline case particular supplement control content contained issue advertisement ask i sure else could call words independent scholarly certainly apply siegfried kasper advertisement er article says emphasis use atypical agents address full range psychotic symptoms minimal adverse effects ensure improved functionality improved patient quality life patients schizophrenia regarded positive reinforcers long term compliance siegfried kasper let find david healy given ghostwritten article years ago expected attach name however made several changes paper fact altered extent longer served originally intended purpose advertisement milnacipran paper originally ghostwritten sent healy forwarded austrian psychiatrist psychiatrist siegfried kasper attached name paper making single change words someone wrote article intended serve advertisement milnacipran kasper affixed name work fact quote guardian original ghostwritten article contained described main commercially important points siegfried kasper kindly agreed author one said name professor kasper university vienna editor journal duly appeared unaltered published article complete original references dr healy work professor kasper told guardian happy content article according one source kasper authored research reports reviews one left wonder many actually written versus written ghostwriters rubber stamped name academics willing sell names reputations university system function independent check claims made drug manufacturers